Supporting diagnostic and therapeutic decision-making
Data-based decision making is predicted to have substantial impact on value-based care. The Center for Medicare & Medicaid Services (CMS) is increasing its emphasis on the use of clinical decision support (CDS) tools, recognizing its role in reducing both care costs and improving care quality. Clinicians who have already adopted CDS systems tend to agree they can help significantly.1 Challenges that can be overcome by utilizing diagnostic and therapeutic decision support include, e.g., the reduction of inappropriate treatment plans for oncology2, a reduction of readmissions and of patient complications due to non-adherence to guidelines.3
Get a preview of decision support tools we will be demonstrating at HIMSS 2020. These tools can help provide access to relevant patient information, enable adherence to evidence-based guidelines, support risk stratification, or facilitate provider-patient discussions about appropriate care.
Supporting AI-powered decision-making will have substantial impact on the expansion of precision medicine.
Leveraging data integration and augmented intelligence technologies, the solution AI-Pathway Companion with its applications, aims to support teams of multidisciplinary experts to ease clinical and operational decisions. AI-Pathway Companion applications enable personalized and standardized patient management and offer process improvement insights through analysis of key performance indicators. The AI-Pathway Companion product suite helps in patient-centric clinical and operational decisions along disease-specific care pathways using augmented intelligence, data integration, and insights from cohort analytics.
The AI-Rad Companion, our family of AI-powered, cloud-based augmented workflow solutions, helps reduce the burden of basic repetitive tasks and may increase diagnostic precision when interpreting medical images. Its solutions provide automatic post-processing of imaging datasets through our AI-powered algorithms and provide case-based decision support. The automation of routine workflows with repetitive tasks and high case volumes helps ease your daily workflows – so that providers can focus on more critical issues.
Medicalis Clinical Decision Support6
Up to 26% of all imaging is ordered incorrectly when placed without evidence-based standards.7 Our Medicalis Clinical Decision Support (CDS) is at the forefront of this development. Based on our knowledge and expertise acquired through more than 15 years of experience in this domain, our solution has been developed with an intuitive design, making it easy for your referring providers to request imaging consultations with evidence support to guide them through the entire process. With a focus on specific modalities, indications, and priority clinical areas for content delivery and by taking an evidence-based and targeted approach, providers can ensure referring physicians are ordering exams for cases where the potential for positive impact on patient care is high, thus increasing the quality of service and providing added value without discouraging the ordering physician.
The digitalization of healthcare can be advanced by utilizing syngo.via – an intelligent multi-modality imaging software. Powerful tools support actionable results that are accessible for better care. With the latest release, syngo.via streamlines the processes around reading and reporting. syngo.via unifies and centralizes intelligent tools in a powerful diagnostic workflow to make your routine tasks more convenient and efficient. It simplifies and speeds up diagnosis with one, consistent, AI powered workflow for routine. At the same time, syngo.via optimizes report creation by integrating established solutions with real-time findings transfer in partnership with Nuance and Cerner. The creation of actionable, structured imaging results and provision of more complete health records with this combined solution may strengthen the role of radiology in clinical care.
Follow us on Social Media
Get the latest news and updates before, during and after HIMSS 2020.
- Follow us on Twitter to get updates from the event in real-time
- Subscribe to our YouTube channel and get video highlights and interviews from our booth
- Subscribe to our eNews newsletter and stay up-to-date on new products and industry trends, customized to your preferences
- Or follow us on LinkedIn, Facebook and Instagram
2DOI: 10.1200/jco.2013.31.15_suppl.6515 Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013) 6515-6515
4AI-Pathway Companion Prostate Cancer is not commercially available in all countries. Due to regulatory reasons the future availability cannot be guaranteed.
AI-Pathway Companion Lung Cancer is currently under Development and is not commercially available. It does not fulfill all the essential requirements according to the European Medical Device Directive (93/42/EEC) and their national implementations.
Please contact your local Siemens Healthineers organization for further details.
5AI-Rad Companion Chest CT (MSK) is pending 510(k) clearance, and is not yet commercially available in the United States. Its future availability cannot be ensured.
AI-Rad Companion Brain MR, Prostate MR are pending 510(k) clearance, and not yet commercially available in the United States.
AI-Rad Companion Chest x-Ray is currently under development; it is not for sale in the United States. Its future availability cannot be guaranteed.
The products do not fulfill all the essential requirements according to the European Medical Device Directive (93/42/EEC) and their national implementations. They are not commercially available in the European Union. Their future availability cannot be ensured.
6Medicalis Clinical Decision Support is not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
7https://innovation.cms.gov/Files/reports/MedicareImagingDemoEvalRTC.pdf, page 51.
8syngo.via can be used as a standalone device or together with a variety of syngo.via-based software options, which are medical devices in their own right.
syngo.via and the syngo.via based software options are not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.